Novavax Covid Vaccine Authorized in Indonesia

[ad_1] Novavax, a Maryland-based company that received $1.75 billion from the United States government to develop a protein-based Covid-19 vaccine. announced He received an emergency clearance for his vaccine in Indonesia on Monday. After months of production delays, this is the first authorization for Novavax and its manufacturing partner, Serum Institute of India. They have …